Marex Group PLC MRX
71.31
(1.38)
(1.90%)
as of 25 Sep
- Market cap
- $5.2B
- P/E
- 16.9×
Follow MRX
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
9.63 | — | 10.54 | — |
P/S ratio |
1.37 | — | 1.55 | — | |
P/FCF ratio |
1.16 | — | 1.55 | — | |
P/Operating CF |
2.60 | — | 3.45 | — | |
P/B ratio |
2.04 | — | 2.38 | — | |
Price to Tangible BV |
2.79 | — | 3.15 | — | |
EV/Sales |
(1.66) | — | (1.42) | — | |
EV/EBITDA |
0.00 | — | 0.00 | — | |
EV/Operating CF |
(1.40) | — | (1.40) | — | |
EV/FCF |
(1.41) | — | (1.42) | — | |
Quick Ratio |
0.84 | 0.79 | 0.78 | 0.83 | |
Current Ratio |
1.11 | 1.09 | 1.08 | 1.09 | |
Net Debt/EBITDA |
(56.33) | 0.00 | (41.98) | 0.00 | |
Debt/Assets |
24.05% | 23.72% | 23.89% | 22.00% | |
Debt/Equity |
6.69 | 6.51 | 6.48 | 4.96 | |
Asset Turnover |
0.07 | 0.00 | 0.07 | 0.00 | |
Operating CF/Net income |
0.00 | — | 0.00 | 0.00 | |
Capex/Depreciation |
— | — | — | (0.58) | |
Interest Coverage |
0.00 | — | 0.00 | — | |
Research and Development Expense of Revenue |
0.00% | — | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
60.26% | — | 60.78% | — | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | 0.00% | |
Graham Net Nets |
0.16 | — | 0.08 | — | |
Graham Number |
36.00 | — | 42.25 | — | |
Earnings Yield |
10.38% | — | 9.49% | — | |
Free Cash Flow Yield |
85.90% | — | 64.71% | — | |
Revenue per Share |
6.76 | — | 9.64 | — | |
Operating CF per Share |
0.00 | — | 0.00 | 0.00 | |
Capex per Share |
0.00 | — | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | — | 0.00 | 0.00 | |
Cash per Share |
184.83 | 0.00 | 207.01 | 0.00 | |
Shareholders Equity per Share |
16.51 | 0.00 | 18.76 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.51 | 0.00 | 18.76 | 0.00 | |
Free Cash Flow |
— | — | — | 687.90 | |
Working Capital |
3,103.60 | 2,733.50 | 2,647.00 | 3,270.00 | |
Capital Expenditures |
— | — | — | (13.50) | |
Net Current Asset Value |
374.10 | 285.40 | 240.90 | 347.40 | |
EV/EBIT |
0.00 | — | 0.00 | — | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
Net Profit Margin |
15.11% | — | 16.24% | — | |
Price to Operating Income |
3.54 | — | 4.27 | — | |
| Other line items | |||||
Average Receivables |
7,799.40 | 9,293.25 | 8,972.50 | 10,428.40 | |
Average Payables |
10,803.30 | 11,348.40 | 11,984.85 | 13,118.90 | |
Average Inventory |
151.25 | 259.75 | 202.10 | 397.65 | |
Average Assets |
26,222.90 | 29,493.80 | 30,442.30 | 36,657.20 | |
Average Common Equity |
1,032.95 | 1,120.25 | 1,196.35 | 1,490.00 |
Columns are period end dates